SAB Biotherapeutics, Inc 10-Q for FY2025 Q3
SAB Biotherapeutics, Inc. (SABS)
10-Q
2025-11-14
For: 2025-09-30
View Original
Added on
April 10, 2026
About this 10-Q
SAB Biotherapeutics, Inc filed this 10-Q on November 14, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).
Headline figures
Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net income
- $45.45M
- compared with a net loss of $10.35M a year earlier
- Diluted EPS
- -$0.21
- compared with -$1.12 a year earlier